To minimize any influence of MSA subtype, we used mixed MSA cases for the remainder of the study in which we investigated cytokine and chemokine protein expression, the CX3CL1/CX3CR1 microglial regulatory pathway and inflammatory gene expression. This evidence concerns the gene CX3CR1 and multiple system atrophy.